IASLC tumor budding grade identifies high-risk patients with resected lung squamous cell carcinoma

A recently projected International Association for the Study of Lung Cancer (IASLC) tumor budding–based grading strategy successfully identified patients with resected lung squamous compartment carcinoma (SqCC) astatine higher hazard of mediocre outcomes and showed imaginable to assistance usher enactment for adjuvant chemotherapy, according to probe presented astatine the IASLC 2026 World Conference connected Lung Cancer (WCLC).